SweetGredients

SweetGredients is a joint venture between BRAIN Biotech AG and Roquette focused on the development of natural, high-intensity sweetener proteins. The company leverages precision fermentation technology to produce Brazzein, a protein originally derived from the Oubli fruit that is significantly sweeter than sucrose. By utilizing microbial strain engineering, SweetGredients provides a sustainable and scalable alternative to traditional sugar and synthetic sweeteners. The partnership combines BRAIN’s expertise in biotechnology and enzyme discovery with Roquette’s global leadership in plant-based ingredients and large-scale manufacturing. Their primary goal is to address the global health challenge of sugar reduction in the food and beverage industry to help prevent metabolic diseases. The company's lead product, Brazzein, offers a superior taste profile and stability, making it suitable for a wide range of commercial applications.